Zobrazeno 1 - 10
of 614
pro vyhledávání: '"T. E. Mollnes"'
Autor:
S. F. Jørgensen, M. E. Macpherson, T. Bjørnetrø, K. Holm, M. Kummen, A. Rashidi, A. E. Michelsen, T. Lekva, B. Halvorsen, M. Trøseid, T. E. Mollnes, R. K. Berge, A. Yndestad, T. Ueland, T. H. Karlsen, P. Aukrust, J. R. Hov, B. Fevang
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-1 (2024)
Externí odkaz:
https://doaj.org/article/91f739ce296143479e08c8c2060570b4
Autor:
M-K. Torp, T. Ranheim, C. Schjalm, M. Hjorth, C.M. Heiestad, K. T. Dalen, P. H. Nilsson, T. E. Mollnes, S. E. Pischke, E. Lien, J. Vaage, A. Yndestad, K-O. Stensløkken
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
The innate immune system is rapidly activated during myocardial infarction and blockade of extracellular complement system reduces infarct size. Intracellular complement, however, appears to be closely linked to metabolic pathways and its role in isc
Externí odkaz:
https://doaj.org/article/9ea06da6044c4858820618ed50943f7b
Autor:
Viktoriia Chaban, Ingebjørg Seljeflot, Geir Øystein Andersen, Camilla Schjalm, T. E. Mollnes, Espen Rostrup Nakstad, Kjetil Sunde, Søren Erik Pischke, Henrik Stær-Jensen, Christofer Lundqvist, Jurate Šaltytė-Benth
Publikováno v:
Molecular Immunology. 102:138
Autor:
T. E. Mollnes
Publikováno v:
Scandinavian Journal of Immunology. 21:607-613
A double-antibody biotin-avidin enzyme-linked immunosorbenl assay (ELISA) for quantification of the C3d split products is described. Polyethylene glycol MXJO was used to precipitate large C3 molecules, and the C3d-containing supernatant was used in t
Autor:
Nicolussi P; Istituto Zooprofilattico Sperimentale della Sardegna, Sassari, 07100, Italy., Pilo G; Istituto Zooprofilattico Sperimentale della Sardegna, Sassari, 07100, Italy., Cancedda MG; Istituto Zooprofilattico Sperimentale della Sardegna, Sassari, 07100, Italy., Peng G; Institute of Environmental Medicine, Karolinska Institutet, Stockholm, 17177, Sweden., Chau NDQ; CNRS, Immunology, Immunopathology and Therapeutic Chemistry, UPR 3572, University of Strasbourg ISIS, Strasbourg, 67000, France., De la Cadena A; Dipartimento di Fisica, Politecnico di Milano, Milan, 20133, Italy., Vanna R; Istituto di Fotonica e Nanotecnologie - CNR, Milan, 20133, Italy., Samad YA; Cambridge Graphene Centre, University of Cambridge, Cambridge, CB3 0FA, UK.; Department of Aerospace Engineering, Khalifa University of Science & Technology, Abu Dhabi, 127788, UAE., Ahmed T; Cambridge Graphene Centre, University of Cambridge, Cambridge, CB3 0FA, UK., Marcellino J; Cambridge Graphene Centre, University of Cambridge, Cambridge, CB3 0FA, UK., Tedde G; Istituto Zooprofilattico Sperimentale della Sardegna, Sassari, 07100, Italy., Giro L; ImmuneNano Laboratory, Department of Biomedical Sciences, University of Padua, Padua, 35131, Italy., Ylmazer A; Department of Biomedical Engineering, Ankara University, Ankara, 06830, Turkey., Loi F; Istituto Zooprofilattico Sperimentale della Sardegna, Sassari, 07100, Italy., Carta G; Istituto Zooprofilattico Sperimentale della Sardegna, Sassari, 07100, Italy., Secchi L; Istituto Zooprofilattico Sperimentale della Sardegna, Sassari, 07100, Italy., Dei Giudici S; Istituto Zooprofilattico Sperimentale della Sardegna, Sassari, 07100, Italy., Macciocu S; Istituto Zooprofilattico Sperimentale della Sardegna, Sassari, 07100, Italy., Polli D; Dipartimento di Fisica, Politecnico di Milano, Milan, 20133, Italy.; Istituto di Fotonica e Nanotecnologie - CNR, Milan, 20133, Italy., Nishina Y; Graduate School of Natural Science and Technology, Okayama University, Tsushimanaka, Kita-ku, Okayama, 700-8530, Japan.; Research Core for Interdisciplinary Sciences, Okayama University, Tsushimanaka, Kita-ku, Okayama, 700-8530, Japan., Ligios C; Istituto Zooprofilattico Sperimentale della Sardegna, Sassari, 07100, Italy., Cerullo G; Dipartimento di Fisica, Politecnico di Milano, Milan, 20133, Italy.; Istituto di Fotonica e Nanotecnologie - CNR, Milan, 20133, Italy., Ferrari A; Cambridge Graphene Centre, University of Cambridge, Cambridge, CB3 0FA, UK., Bianco A; CNRS, Immunology, Immunopathology and Therapeutic Chemistry, UPR 3572, University of Strasbourg ISIS, Strasbourg, 67000, France., Fadeel B; Institute of Environmental Medicine, Karolinska Institutet, Stockholm, 17177, Sweden., Franzoni G; Istituto Zooprofilattico Sperimentale della Sardegna, Sassari, 07100, Italy., Delogu LG; ImmuneNano Laboratory, Department of Biomedical Sciences, University of Padua, Padua, 35131, Italy.; Department of Biological Sciences, Khalifa University of Science and Technology, Abu Dhabi, 127788, UAE.
Publikováno v:
Advanced healthcare materials [Adv Healthc Mater] 2024 Oct 10, pp. e2401783. Date of Electronic Publication: 2024 Oct 10.
Publikováno v:
Molecular Immunology. 67:1-2
Preface : Special Issue 15th European Meeting on Complement in Human Disease 2015, Uppsala, Sweden
Publikováno v:
Scandinavian Journal of Immunology. 48:312-317
Several complement modulating effects of high-dose intravenous immunoglobulins (IVIG) have been proposed from in vitro studies and experimental animal models. However, the in vivo effects of IVIG on plasma complement in humans are yet not known. We h
Autor:
O L, Brekke, C, Waage, D, Christiansen, H, Fure, H, Qu, John D, Lambris, B, Østerud, E W, Nielsen, T E, Mollnes
Publikováno v:
Advances in experimental medicine and biology. 735
The complement pathway and CD14 play essential roles in inflammation, but little is known about the relative roles of complement and CD14 in E. coli-induced tissue factor (TF) mRNA upregulation, expression by monocytes, and functional activity in hum
Autor:
T. E. Mollnes, Kjell Saatvedt, Harald Lindberg, Egil Seem, Svein Michelsen, Odd Geiran, Thore H Pedersen
Publikováno v:
Cardiovascular Research. 31:596-602
Objective: The purpose of the study was to evaluate the clinical and hemodynamic effect of intraoperative extracorporeal ultrafiltration (UF) and its potential in reducing the plasma concentration of circulating cytokines and complement activation pr
Publikováno v:
Scandinavian journal of immunology. 76(3)
Low-density lipoprotein (LDL) apheresis is an extracorporeal treatment modality used in high-risk patients when LDL cholesterol levels cannot be reduced adequately with medication. The treatment is highly effective, but could be affected by potential